Triveni Bio

Triveni Bio is a clinical-stage biotechnology company developing genetics-informed antibody therapeutics for immune and inflammatory diseases. It combines advanced antibody engineering with a precision-medicine approach to identify novel disease targets and create first-in-class treatments. The company’s pipeline includes programs for immunological conditions such as atopic dermatitis, while its mission is to redefine the standard of care for complex diseases and patients in need.